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Aims: 
 
We assessed prospectively the association between occurrence of
post-discharge non–CABG-related TIMI major and minor bleedings and post
treatment platelet reactivity in patients with Non ST Elevation Acute Coronary
Syndrome (NSTE ACS).
 
Methods and Results:
 
 597 consecutive patients admitted with NSTE
ACS were prospectively included. Between hospital discharge and one
month follow-up, we observed 16 (2.7%) non–CABG-related TIMI hemor-
rhagic complications including 5 (0.84%) major and 11 (1.8%) minor bleeds.
Patients with bleeding had significantly lower post treatment values of ADP-
induced aggregation (43±14% versus. 56±19%, P=0.002) and platelet reac-
tivity index VASP (43±14% versus 54±23%; P=0.04) and a trend for lower
values of arachidonic acid-induced aggregation (2.4±5.4 versus 13±21;
P=0.27). After stratification by quartiles based on post treatment ADP-
induced platelet aggregation, we identified patients in the first quartile as
hyper-responders with very low post treatment platelet reactivity, below
<40%. The risk of TIMI major and minor bleeding was significantly higher
in the first quartile of hyper-responders than in the others quartiles: 10
(6.6%) versus 6 (1.4%), p=0.001.
 
Conclusion:
 
 Our results suggest that assessment of post treatment platelet
reactivity might be used to detect hyper responders to antiplatelet therapy with
higher risk of non-CABG related bleedings and tailor antiplatelet therapy
according to both ischemic and bleeding risk. 
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Background:
 
 Discrepancies may exist between guidelines and their imple-
mentation in daily practice. The aim of this study was to analyze management
of acute myocardial infarction (AMI) in three population registries.
 
Methods: 
 
In three areas of France, we registered in 2006 all acute coronary
syndromes (ACS) aged 35-74 years, without any previous history of coronary
heart disease, in the 3 MONICA Registries of Lille, Strasbourg and Toulouse.
We obtained data before, during and after hospitalization for all consecutive
cases of ACS in all hospitals covered by the 3 registries. In order to compare
with the 2008 ESC guidelines on AMI, we restricted our analysis in patients
(pts) with a discharge diagnosis of incident AMI.
 
Results:
 
 Among 2018 incident ACS hospitalized in 2006, 1212 (60%)
were discharged with a diagnosis of incident AMI (mean age 57.2 ± 10.3,
79.2% men). The delay between symptom onset and first medical contact was
<1 h in 25%, <2 h in 45% and <4 h in 59% of pts. The first medical contact
was a physician-manned ambulance for 48% of pts. The delay between
symptom onset and hospitalization was <1 h in 8%, <2 h in 26% and <4 h in
53% of pts. Pre-hospital care included pre-hospital fibrinolysis in 10.6%,
aspirin in 35.5% and clopidogrel in 15.1% of pts. Among all AMI, 74% were
hospitalized in a percutaneous coronary intervention (PCI)-capable hospital
and 53% had a primary angioplasty. During the first 24 h of hospitalization,
60.7% had PCI, 5.0% in-hospital fibrinolysis, 89.2% aspirin, 86.2% clopi-
 
dogrel, 66.0% 
 
β
 
-blockers, 60.7% angiotensin-converting enzyme (ACE) inhib-
itors and 42.2% statins. Among discharged pts, 93.7% had aspirin, 86.3%
clopidogrel, 87.0% 
 
β
 
-blockers, 75.6% ACE inhibitors and 90.8% had statins.
One month mortality was 6.0%.
 
Conclusion:
 
 The management of AMI has greatly improved in France.
However, the first medical contact often remains a general practitioner and
about half of the pts are admitted at hospital more than 4 hours after symptom
onset.
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Objective:
 
 Although delayed enhanced CMR has become a reference
method for infarct size quantification, there is no ideal method to quantify total
infarct size in a routine clinical practice. In a prospective study we compared
the performance and post-processing time of a global visual scoring method to
standard quantitative planimetry and we compared both methods to the peak
values of myocardial biomarkers.
 
Material and Methods:
 
 This study had local ethics committee
approval; all patients gave written informed consent. 136 patients admitted
with reperfused AMI to our intensive care unit had a complete CMR study
with Gadolinium-contrast injection 4±2 days after admission. A global
visual score was defined on a 17-segment model and compared with the
quntitative planimetric evaluation of hyperenhancement. The peak values
of serum troponin I (TnI) and creatine kinase (CK) release were measured
in each patient.
 
Results: 
 
The mean percentage of hyperenhanced myocardium determined
by the quantitative planimetry method was (21.3 ± 14.1) with a range of 0-
68,6%. There was an excellent correlation between quantitative planimetry and
visual global scoring for the hyperenhancement extent’s measurement (r=0.91;
y=1.04x+3,2; SEE=1.2; P<0.001) The Bland-Altman plot showed a good con-
cordance between the two approaches (mean of the differences = –4.04% with
a standard deviation of 6.9).
Mean post-processing time for quantitative planimetry was significantly
longer than visual scoring post-processing time (23.7± 5.7 minutes VS 5.0
± 1.1 minutes respectively, P<0.001). Correlation between peak CK and
quantitative planimetry was r=0.71 (P<0.001) and r=0.75 (P<0.001) with
visual global scoring. Correlation between peak troponin I and quantitative
planimetry was r= 0.69 (P<0.001) and r= 0.70 (P<0.001) with visual global
scoring.
 
Conclusion:
 
 A visual approach based on a 17-segment model allows a
rapid and accurate assessment of the myocardial global delayed enhancement.
This scoring method could be used on a daily practice and useful for the man-
agement strategy of post-MI patients.
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